Company / Free Cash Flow
ROCKET PHARMACEUTICALS, INC. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$215.6M
FY2025
5-year range
-$215.6M / -$87.9M
FY2021-FY2025
Trend
-15.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 5 consecutive years, from -$55M in FY2020 to -$216M in FY2025.
Based on SEC 10-K filings.
-$216M in FY2025.
Declined from -$129M to -$216M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s free cash flow has declined for 5 consecutive years.
- In FY2025, free cash flow decreased 15.6% year-over-year.
- Peak free cash flow was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$215.6M | -15.6% |
| FY2024 | -$186.5M | -44.8% |
| FY2023 | -$128.8M | -35.2% |
| FY2022 | -$95.2M | -8.3% |
| FY2021 | -$87.9M | -59.2% |
| FY2020 | -$55.2M | +0.0% |
| FY2019 | -$55.2M | -846.2% |
| FY2018 | -$5.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026